Company takes next step in planned uplisting from OTC Markets MIAMI, FL / ACCESS Newswire / November 24, 2025 / Luminar Media Group, Inc. (OTCID:LRGR) ("Luminar" or the "Company"), a diversified ...
On September 8, 2025, Nasdaq submitted a first-of-its-kind application to the Securities and Exchange Commission (SEC) to amend Nasdaq rules to ...
Achieve Life Sciences Inc. (NASDAQ:ACHV) is one of the Canadian penny stocks to buy right now. Lake Street’s Thomas Flaten ...
Fuxing China Group first announced that it was looking to explore a secondary listing on Nasdaq on Dec 31, 2021. At the time, the group said the potential listing and placement of new shares in ...
10hon MSN
William Blair Maintains Market Perform Rating on uniQure (QURE) Despite AMT-130 Approval Uncertainty
Qure N.V. (NASDAQ:QURE) ranks among the most oversold biotech stocks to invest in. William Blair reaffirmed its Market Perform rating for uniQure N.V.
TipRanks on MSN
NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs
Austin, Texas, United States, November 17th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP) reported third-quarter 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback